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The typeVI secretion systems (T6SS) are present in about a quarter of all Gram-
negative bacteria. Several key components of T6SS are evolutionarily related to
components of contractile nanomachines such as phages and R-type pyocins.
The T6SS assembly is initiated by formation of amembrane complex that binds
a phage-like baseplate with a sharp spike, and this is followed by polymeriz-
ation of a long rigid inner tube and an outer contractile sheath. Effectors are
preloaded onto the spike or into the tube during the assembly by various
mechanisms. Contraction of the sheath releases an unprecedented amount of
energy, which is used to thrust the spike and tubewith the associated effectors
out of the effector cell and across membranes of both bacterial and eukaryotic
target cells. Subunits of the contracted sheath are recycled by T6SS-specific
unfoldase to allow for a new round of assembly. Live-cell imaging has
shown that the assembly is highly dynamic and its subcellular localization
is in certain bacteria regulated with a remarkable precision. Through the
action of effectors, T6SS hasmainly been shown to contribute to pathogenicity
and competition between bacteria. This review summarizes the knowledge
that has contributed to our current understanding of T6SS mode of action.1. Discovery of novel secretion system
Gram-negative bacteria use various secretion systems to deliver proteins from
the bacterial cytosol to the extracellular space or into target cells, and quite often
these systems are important virulence factors [1]. Indeed, the type VI secretion
system (T6SS) was discovered when Pukatzki et al. [2] used Dictyostelium
discoideum as a model organism to screen many isolates of Vibrio cholerae for
novel virulence factors. The screen identified non-O1, non-O139 V. cholerae strain
V52 that uses a conserved cluster of genes to resist a predation byamoebae. Similar
clusters of genes were previously identified as conserved in many other Gram-
negative bacteria but their function was not known [3]. Importantly, Pukatzki
et al. showed that the gene cluster is responsible for secretion of haemolysin-
corregulated protein (Hcp), which was previously identified as secreted by an
unknown mechanism [4], and three VgrG proteins one of which was previously
shown to contain toxic actin cross-linking domain [5]. Shortly after characteriza-
tion of T6SS in V. cholerae, one of the three T6SS clusters of Pseudomonas
aeruginosa was shown to secrete Hcp in vitro and because the Hcp was also
detected in the sputum of cystic fibrosis patients infected by P. aeruginosa it was
suggested that this system could be important for pathogenesis [6].
Transport of proteins across a barrier needs a source of energy and accord-
ingly the early analyses of T6SS cluster components identified two putative
ATPases, TssM (IcmF) and ClpV (TssH). Full-length TssM protein was shown
to be important for T6SS function in V. cholerae [2]; however, the early obser-
vation that the ATPase activity of TssM is dispensable for T6SS activity in
Edwardsiella tarda [7] indicated that ClpV could be the essential ATPase power-
ing the T6SS and TssM could play an important structural role. Indeed,
Mougous et al. [6] showed that localization of ClpV, detected by fluorescence
microscopy, correlates with T6SS activity and that its ATPase activity is necess-
ary for Hcp secretion. ClpV is similar to other AAA (ATPases Associated with
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activity was previously also correlated with the ability of Sal-
monella typhimurium and Yersinia pseudotuberculosis cells to
enter epithelial cells [8]. Since ClpB and homologous AAA
proteins are known to unfold and thread substrates through
their pore, it seemed reasonable that ClpV could be involved
in pushing T6SS substrates across the cell membranes. Inter-
estingly, Hcp crystal structure suggested that stacks of Hcp
hexamers could form a channel for T6SS substrates [6].
Overall, these initial studies clearly showed that a conserved
gene cluster was responsible for protein secretion and virulence
by a mechanism distinct from previously described secretion
systems [2,6]. For details of the work that predated the
discovery of T6SS, see the reviews by Filloux et al. [9] and
Bingle et al. [10].
Discovery of T6SS triggered a wide range of follow up
research focused on answering the basic questions such as:
What is the molecular mechanism of type VI secretion?
How is T6SS regulated? What are the effectors that are
secreted by various organisms and what is their mode of
action? How important is T6SS during pathogenesis or in
the environment? Over a decade of research led by many lab-
oratories hugely improved our understanding of T6SS. Many
comprehensive reviews about different aspects of T6SS were
written recently, either with a broad view [11–13], or with a
focus on effectors [14,15] or on structural aspects [1,16–18].
Here, I will review the progress that has been made towards
understanding the molecular mechanism of protein secretion
by T6SS and discuss its unique mode of action.2. Towards an ‘inverted phage tail’ model of
T6SS function
A model of T6SS mode of action changed fundamentally after
the discovery that many critical components of T6SS are struc-
turally and thus also potentially functionally homologous to
components of contractile phage tails. First, secreted VgrG
proteins were shown to be structural homologues of T4
phage spike complex gp5–gp27 [19,20]. Hcp protein was
shown to be a structural homologue of a phage tube protein
[19,21]. Moreover, structural modelling and predictions
suggested that gp25, a conserved component of T4 phage base-
plate, is homologous to an essential T6SS protein, TssE
[10,19,22]. Surprisingly, Bo¨nemann et al. [23] showed that the
substrate of ClpV was a cytosolic protein VipB (TssC) and
not the secreted proteins Hcp and VgrG. The authors also
nicely showed that VipA (TssB) and VipB proteins assembled
into a tubular polymer that can be disassembled by ClpV in
vitro [23]. Even though the biological significance of this tubu-
lar structurewas not immediately clear, Leiman et al. [19] noted
that its overall structure resembled T4 phage polysheath. Over-
all, these observations suggested that T6SS could function as an
inverted phage tail and use the contraction of a sheath-like
structure to drive the Hcp tube with associated VgrG-effector
spike out of the cells [19,24,25].
The first idea about overall structure and mode of action of
T6SS came from a study of T6SS in V. cholerae [26]. This study
was possible due to an enormous progress in electron
microscopy (EM) of bacterial ultrastructures in three dimensions
in their native state inside intact cells [27,28]. Whole cell cryo-
electron tomography showed that T6SS indeed resembles a
long phage tail attached to the cell envelope by a membraneanchor. The tail was visualized in two conformations, extended
and contracted, which resembled the previously identified
VipA/VipB sheath [23,26]. The contracted sheath structures
were ingeneral shorter,widerandapparently emptyas opposed
to the extended structure that had an extra density inside, which
was suggested to be an Hcp tube [26]. The realization that the
extended structures span the whole bacterial cytosol initiated
fluorescence microscopy analysis of dynamics and subcellular
localization of T6SS assembly by imaging of VipA-GFP in live
cells. It was shown that T6SS sheath assembly in V. cholerae
takes about 20–30 s, then the sheath contracts to about half its
length in less than 5 ms and the contracted sheath is disas-
sembled over tens of seconds in a ClpV-dependent manner
[26]. Since then, the T6SS dynamics was described using live-
cell imaging in more detail in V. cholerae, P. aeruginosa and
Escherichia coli [29–31]. In summary, thedescription of anoverall
structure and fast dynamics of the assembly showed that T6SS
has a fundamentally different mode of action from that of
other known secretion systems (figure 1).3. Initiation and regulation of T6SS assembly
Live-cell fluorescence microscopy showed that the T6SS
sheath does not assemble in cells lacking critical T6SS com-
ponents [26,31], suggesting that the membrane anchoring
complex and a baseplate are necessary for initiation of tube
and sheath polymerization.
Recently, great progress has been made towards under-
standing of T6SS tail attachment to a bacterial cell envelope.
The minimal membrane complex is formed by the inner mem-
brane proteins TssL and TssM, which are homologues of type
IV secretion system components IcmF and DotU, and an
outer membrane lipoprotein TssJ [32–37]. TssM is anchored
into an inner membrane by three transmembrane segments
and interacts with TssL [36]. Furthermore, TssJ was shown to
form a complex with TssM and TssL [33,35]. The OmpA-like
extension domain of TssL, or in some organisms like E. coli an
additional accessory protein TagL, anchors the membrane
complex to the peptidoglycan [38]. Structures of TssL from
Francisella novicida, V. cholerae and E. coli [39–41], of TssJ from
P. aeruginosa, E. coli and Serratia marcescens [35,42,43] and partial
structure of E. coli TssM C-terminal domain alone or in a com-
plex with TssJ were solved, providing a very detailed picture of
the membrane complex assembly [34].
Importantly, the whole TssJLM complex of E. coli was
recently isolated and resolved at 12 A˚ resolution by EM, provid-
ing an unprecedented insight into the overall assembly [34]. The
complex has fivefold symmetry and is composed of 10 copies of
each component (TssM, L, J) with an overall mass of 1.7 MDa.
The complex forms a 30 nm high and 20 nm wide rocket
shaped structure that spans both inner and outer membranes
with only a narrow pore. The complex was proposed to
undergo conformational changes to accommodate the spike
with effectors and Hcp tube passing through [34]. Importantly,
functional N-terminal fusions of sfGFP to TssM and TssL loca-
lize into one or two static and stable foci on the cell periphery
and the T6SS sheath polymerizes from these stable complexes
repeatedly. Furthermore, TssJ was shown to be the nucleation
factor for the membrane complex assembly [34].
Functions of TssE, TssF, TssG, TssK and TssA proteins are
currently not well understood. These proteins could be
involved in formation of a baseplate connecting the T6SS
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Figure 1. T6SS mode of action. Assembly of T6SS in an extended ‘ready to fire’ conformation starts by the assembly of a membrane complex composed of TssJLM.
Effector domains can be either present on VgrG C-terminus and PAAR C- and N-termini or be preloaded onto VgrG/PAAR spike complex, optionally with an assist-
ance of non-secreted chaperones. VgrG/PAAR/effector complex possibly together with TssEFG and K proteins form the baseplate in a conformation that initiates
assembly of tube and sheath. Hexameric rings of Hcp, potentially with bound effectors, assemble to a long rigid tube that serves as a template for the assembly of
an extended VipA/VipB sheath. Potential conformational change in the baseplate/membrane complex triggers the sheath contraction, which pushes the Hcp tube
with the VgrG/PAAR spike and associated effectors from the cell to an extracellular space or across a target cell membrane. The contracted sheath is specifically
recognized by ClpV ATPase, which unfolds the subunits and thus recycles them for a new round of assembly of an extended sheath.
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in E. coli, TssK was shown to interact with the membrane com-
plex protein TssL as well as with Hcp and VipB components of
the sheath [44] and, in S.marcescens, TssKwas shown to interact
with TssF and TssG [45]. Because TssE and its phage homol-
ogues have a fold that is similar to the fold of the inner
domain of T6SS or phage sheath, it was suggested that TssE
could be directly binding the sheath [24,46,47].
As reviewed recently, the expression of T6SS gene clusters is
regulated by various environmental clues and many organisms
even havemultiple independently regulated T6SSwith different
functions [17,48,49]. However, from a structural point of view,
it is interesting that the T6SS assembly is regulated also post-
translationally in some organisms. For example, in the first of
the three T6SS clusters of P. aeruginosa (H1-T6SS), the accessory
protein TagH is phosphorylated by a cognate serine–threonine
kinase, PpkA, and dephosphorylated by a phosphatase, PppA
[50]. TagH is also phosphorylated in S. marcescens [51] but in
Agrobacterium tumefaciens T6SS assembly is regulated by phos-
phorylation of TssL [52,53]. In H1-T6SS of P. aeruginosa, PpkA
activation requires a periplasmic protein, TagR [54], which is
anchored to the outer membrane by an interaction with TagQ
[55]. Additionally, TagT and TagS were shown to form aninnermembranecomplexwithATPase activityandact upstream
of PpkA [55]. Interestingly, in P. aeruginosa, the H1-T6SS can
be also activated independently of TagH phosphorylation by
inactivation of another accessory protein, TagF [56].
Live-cell imaging of H1-T6SS dynamics in P. aeruginosa
showed that the cells are able to initiate andsubcellularly localize
the assembly of their T6SS in a response to T6SS activity of
a neighbouring sister cell with a remarkable spatial and tem-
poral precision [29]. Interestingly, it has been also shown that
P. aeruginosa kills T6SSþ organisms such as V. cholerae,
Acinetobacter baylyi or Burkholderia thailandensis better than their
T6SS2mutants [57,58]. This phenotype called ‘duelling’ is regu-
lated by the TagQRST/PpkA signalling cascade [57], which can
also respond to mating-pair formation initiated by T4SS or to
membrane damage induced by polymyxin B [59]. Importantly,
the spatio-temporal regulation of the T6SS assembly allows
P. aeruginosa to preferentially attack T6SSþ cells even in a mix-
ture with T6SS2 cells and this is independent of the level of
T6SS expression in P. aeruginosa [57,59]. However, regulation
of expression level of H1-T6SS in response to lysis of kin cells
furthercontributes to an efficientuse ofT6SS inP. aeruginosa [60].
Overall, these studies suggest that a proper assembly and
structural changes of the membrane complex and baseplate
rstb.royalsocietypublis
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activity. This has an analogy in phages where the assembly of
a baseplate is required for tube and sheath polymerization
[25,61]. Interestingly, achangeof the structure of thephagebase-
plate initiates contraction of the sheath upon binding to the host
cell [25,62,63]. This suggests that contraction of the T6SS sheath
mayalso be triggered by structural changes in the baseplate and
possibly also in the membrane complex (figure 1). hing.org
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In phages, the fully assembled baseplate includes also the spike
complex, which initiates the assembly of a tail tube and an
extended sheath around it [24,64–66]. The integrity of VgrG/
PAAR spike complex was indeed shown to be essential for
T6SS function [2,31,67], and even though the Hcp tube assem-
bly has not been directly visualized yet, it has been shown that
Hcp tube and sheath polymerize by a mechanism similar to
phage [68].
Even before realization that Hcp is a structural homologue
of phage tube protein [19,21], it was proposed that Hcp could
form a conduit (channel) for T6SS effectors because Hcp of
P. aeruginosa was shown to form hexameric rings that were
stacked into a tube in a crystal lattice [6]. Indeed, introducing
cysteines to a surface between Hcp rings can lead to cross-link-
ing of Hcp into a tube in vitro [69,70]. Similarly, in E. coli, by
positioning cysteine on Hcp to probe various possible assem-
blies of Hcp rings, it was shown that Hcp rings assemble
head-to-tail in vivo and that this assembly is dependent on
the presence of T6SS components essential for tail assembly
[68]. It is important to note that in these studies cysteine
cross-links were designed for Hcp rings stacked one on top
of another (head to tail) without any helical twist [68–70].
T4 phage extended sheath assembly is kinetically driven by
interaction of sheath monomers with tube template [64,71]. In
T6SS, Hcp was shown to interact with the VipA component of
the T6SS sheath using a bacterial two hybrid system [68] and
the extended sheath does not assemble in the absence of Hcp
[31]. N-terminal negatively charged and C-terminal positively
charged residues on Hcp were shown to be important for Hcp
secretion in E. tarda [72]. Since these residues are on the surface
of the Hcp ring, they could be involved in Hcp–sheath
interaction. These experiments suggest that in an extended con-
formation Hcp rings interact with sheath subunits through
charge interactions similarly to interactions described recently
at the atomic level for R-type pyocin [46]. Importantly, an
atomic model of the T6SS sheath shows that its inner layer
has the same fold as the phage sheath, suggesting that the
tube–sheath interaction and the mechanism of assembly is
conserved between phage and T6SS [47]. Interestingly, in the
fully assembled extended tail of R-type pyocin, the inner
tube has the same helical parameters as the outer sheath [46].
It is not known if the length of the T6SS tail is regulated and
whether the assembly is terminated by a cap.5. Powering the secretion by sheath contraction
The contraction of a sheath powers the secretion of effectors
and also puncturing of a target cell membrane by T6SS,
phage or R-type pyocin. Amechanism of T4 phage sheath con-
traction was first proposed based on the EM analysis of
extended, contracted and partially contracted T4 tails [73,74]and further improved based on cryoEM analysis and partial
atomic structure of the gp18 sheath subunit [62,63,75].
Recently, an atomic model of an R-type pyocin particle was
solved in both extended and contracted states, and thus can
serve as amodel for estimation of energy released during a con-
traction [46]. During contraction, rings of sheath collapse
sequentially to form amore compact structure that is stabilized
by newly formed charge interactions [46]. Energy gained
during the contraction of a pyocin sheath was estimated to be
12 kcal mol21 per subunit [46], which is about half of what
was previously measured for the twice as large T4 sheath [65].
To estimate how much energy is released during the con-
traction of the T6SS sheath, atomic models of both states,
including details of Hcp–sheath interaction in the extended
conformation, would be necessary. So far, only atomic models
for contracted states of sheath of V. cholerae and Francisella
tularensis are available [47,76]. Analysis of these atomic
models showed that the T6SS sheath is composed of three
domains. T6SS-specific domain 3 is on the surface of the
sheath and plays a role in the recycling by ClpV (see below).
In the inner two layers of T6SS sheath, subunits have the
same fold as the whole pyocin sheath subunit and individual
subunits are interconnected by a similar mesh of augmented
b-strands in the inner layer of the sheath polymer. This suggests
that a similar amount of energy could be released during a
contraction of pyocin and T6SS sheath [46,47,76].
Assuming that the energy gain per subunit is at least as
big for T6SS as it is for the R-type pyocin and that a 1 mm
long T6SS sheath is composed of approx. 1500 sheath sub-
units, the total energy gain from a single contraction could be
18 000 kcal mol21. Energy that is released by hydrolysis of one
ATP molecule is approx. 11.2 kcal mol21 depending on growth
conditions [77]. Therefore, one contraction event would release
energy equivalent to hydrolysis of 1600 molecules of ATP.
Since the contraction happens in less than 5 ms, to get a similar
poweroutputwould require an equivalent of at least 32 000mol-
ecules ofClpX,whichhas amaximumATPase rate of 10 s21 [78].
For comparison, a syringe-like injection mechanism of Tc toxins
ofPhotorhabdus luminescenswasdescribedat theatomic level and
it was predicted that during a transition of TcA frompre-pore to
pore about 20–66 kcal mol21 of energy is released [79,80].
The speed of substrate translocation is remarkable as well.
Since a sheath contracts to about 50% of its original length, an
average sheath of length of 1 mm moves the VgrG/PAAR/
effector payload at a speed of at least 100 mm s21. For compari-
son, kinesin moves at a rate of around 0.5 mm s21, depending
on the load, and consumes about one ATP molecule per
8 nm [81]. Moreover, in a phage and R-type pyocin, a tip of a
tube rotates as it leaves a baseplate [46,62]. Since it is approxi-
mately one turn per 100 nm for T4 phage tail [62], in the case of
T6SS we could predict up to 10 turns in less than 5 ms, in other
words up to 120 000 revolutions per minute.
Overall, it is quite clear that the amount of energy that is
released during T6SS sheath contraction and the speed at
which a payload moves and rotates is quite remarkable,
suggesting that T6SS has the potential to ‘drill’ large cargo
across membranes.6. Recycling of T6SS sheath by ClpV
It is important to realize that at least in V. cholerae, sheath
unfolding by ClpV ATPase is not essential for T6SS activity.
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E. coli in a T6SS-dependent manner and assemble similar
sheath structures as wild-type cells [26,82]. This is very likely
due to rapid cell growth and de novo synthesis of sheath com-
ponents because contracted sheath was not observed to extend
again or to disintegrate to individual subunits [26]. However,
to allow for successive rounds of assembly of T6SS tail in an
extended conformation, the contracted sheath has to be actively
disassembled by ClpV into individual subunits [23,29]. More-
over, ClpV also disassembles contracted sheaths that can form
from soluble subunits even in the absence of functional T6SS,
and thus increases the concentration of soluble subunits for
efficient sheath assembly [23,31].
ClpV has N-terminal and two AAA domains separated by
a middle domain and its primary sequence is about 35% iden-
tical to ClpB, which is involved in a disassembly of large
protein aggregates [8]. The N-terminal domain of ClpV, com-
posed of eight alpha helices, is structurally similar to those of
ClpA/B/C but contains a ClpV-specific N-terminal a-helix
involved in binding of VipB [83]. Co-crystal structure shows
that residues 15–28 of VipB are recognized by a hydrophobic
groove of the N-terminal domain of ClpV [83]. Point mutations
in the N-terminal domain of ClpV block binding of ClpV to
contracted sheath in vitro [83] and in vivo [29].
ClpV of V. cholerae forms hexameric rings in the presence
of ATP and those rings have higher affinity to VipA/VipB;
moreover, ClpV also binds preferentially to a polymeric
VipA/VipB structure [23,83]. After binding of VipA/VipB,
the VipB N-terminus is threaded through the pore of ClpV
while ATP is hydrolysed. Mutations in the pore were shown
to block sheath disassembly in vitro [23,83], and since the bind-
ing to the substrate is not blocked, the mutant ClpV colocalizes
with contracted sheaths in live cells [29]. It is however not clear
whether the full-length VipB is threaded through the ClpV or if
pulling on VipB leads to destabilization of the whole VipA/
VipB polymer and disassembly to subunits. The amount of
unfolding and length of the substrate has consequences for
energy that is needed for recycling of the contracted sheath.
Preferential binding of ClpV to polymeric structures
suggests that ClpV is not constantly refolding VipA/VipB
sheath subunits; however, since extended and contracted
sheaths are composed of the same subunits, ClpV has to specifi-
cally recognize only the contracted sheaths to allow for
extended sheath assembly. Indeed, high-speed live-cell imaging
of localization of both VipA and ClpV in V. cholerae revealed
that ClpV is dispersed in the cytosol in the presence of an
extended sheath; however, immediately after a contraction it
relocalizes to the contracted sheath [29]. After only few seconds,
amaximumbinding between ClpVand the contracted sheath is
reached and the sheath starts to fall apart to smaller pieces in the
next tens of seconds [29]. This suggests that the surface of the
sheath changes during its contraction (figure 1).
The easiest explanation is that the N-terminal a-helix of
VipB is not accessible to ClpV on an extended sheath but is
exposed on the sheath surface after its contraction. Indeed,
recent medium-resolution structure [84] and also atomic
models of the contracted sheaths of V. cholerae and F. novicida
[47,76] provided the first data to support such a mechanism.
These structures clearly show that the T6SS sheath is composed
of three layers: the inner two layers are highly homologous to
the phage and R-type pyocin sheaths and the surface layer is
specific to T6SS sheaths. Importantly, the surface exposed
part of domain 3 is composed of three N-terminal a-helicesof VipB and two C-terminal a-helices of VipA [47,76]. An
extended T6SS sheath was modelled based on an extended
T4 phage sheath and this showed that domain 3 is likely to
be hidden between sheath strands on the extended sheath
and thus potentially inaccessible to ClpV binding [47,84]. It is
important to realize, however, that the exact localization and
structure of the N-terminus of VipB is unknown because it
was not resolved at a high enough resolution [47,76,84]. Alter-
natively, new interactions that are established on the contracted
sheath may induce destabilization of interactions between
a-helices in domain 3 and thus expose the N-terminus of
VipB for ClpV binding. Clearly, atomic models of T6SS tail in
both extended and contracted states and biophysical measure-
ments are necessary to fully understand the molecular
mechanism of sheath disassembly.
In some T6SS, such asH1-T6SS of P. aeruginosa, sheath recy-
cling is apparently more complicated. The structure of the
N-terminal domain ofP. aeruginosaClpVwas found to bediffer-
ent from that of V. cholerae ClpV. This change blocks binding of
the N-terminus of VipB by the ClpV N-terminal domain
suggesting a differentmechanismof sheath recycling [85]. Inter-
estingly, anaccessoryproteinHsiE1/TagJ, not essential for T6SS
function, was shown to bind to both the VipA N-terminus and
ClpV [85,86].V. choleraeVipAN-terminus seems to be buried in
domain 2 of a sheath and thus is probably accessible only from
the end of the T6SS sheath but unlikely from the sheath surface
[47,84]. It was therefore suggested that ClpV–VipB interaction,
different from ClpV–VipB interaction in V. cholerae, leads to an
initial fragmentation of a contracted sheath and thus exposure of
free ends of the contracted sheaths, which in turn increases sub-
sequent recruitment of TagJ/ClpV for a complete disassembly
[85]. This mechanism could make the whole recycling process
more efficient because VipA is a smaller protein and its unfold-
ing might require less ATP. The process could be faster because
of simultaneousdisassembly fromendsandsides of sheath frag-
ments. This mechanism may be also important for preventing
aggregation of sheath monomers similarly to what was shown
forClpV inV. cholerae [31]. Itwill be interesting to learn howdis-
assembly of an assembled extended sheath is prevented from
the exposed end.7. Potential costs of T6SS secretion
Contracted sheath has its VipA/VipB rings about 2.1 nm apart
[47,84] and is formed from an extended sheath that is about
twice as long and usually stretches across the whole width of
a cell [26]. Therefore assuming a 1 mm long extended sheath,
the full width of an average sized bacterial cell, one sheath
structure is composed of approximately 250 rings and thus
about 1500 subunits of VipA and VipB. Since ClpV probably
works similarly to other AAAunfoldases, the cost for remodel-
ling of sheath could probably be separated into two parts:
(i) the cost of denaturation of sheath subunits and (ii) the cost
of translocation of the unfolded VipB protein through the
ClpV pore. The cost of denaturation varies hugely based on
local stability of the protein that is being unfolded and can be
as little as a few ATP molecules, up to hundreds of ATP mol-
ecules [78]. To minimize this cost, the VipA/VipB subunit
could be optimized for cooperative unfolding and low stability
of the region next theVipBN-terminus. The cost of polypeptide
translocation through the pore depends on the length of a sub-
strate and was estimated to be approximately one ATP per
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strate [78]. If indeed full-length VipB protein were to be
threaded through ClpV, up to 500 molecules of ATP could be
consumed per subunit and that could be as much as 750 000
molecules of ATP for a single sheath. However, it is possible
that it is not necessary to unfold the full-length VipB to disas-
semble a contracted sheath. As ClpV pulls on the VipB
N-terminus, the sheath polymer could be destabilized
and broken into individual subunits. The unfolding of VipB
could be then terminated by dissociation of ClpV from the
monomeric sheath subunit, thus saving ATP.
Another important cost comes from the fact that Hcp is a
structural component, which is secreted into the environment
in large quantities in many T6SSþ organisms. Hcp can
be detected as an abundant secreted protein in organisms
such as V. cholerae, A. baylyi, S. marcescens, P. aeruginosa and
E. tarda [2,6,7,67,87]. Because of the extensive structural and
functional homology between T6SS and contractile tails, it is
probably safe to assume that each ring of sheath interacts
with one ring of Hcp as it is in the R-type pyocin [46]. This
means that up to 700 molecules of Hcp are secreted out of
the cell every time a full-length sheath contracts. Assuming
only one contraction per 5 min and the molecular weight of
Hcp to be 18 kDa, then 109 cells (1 ml of OD 1 culture) will
secrete about 250 ng of Hcp into the supernatant in 1 h. This
seems to be a huge waste especially considering that only
three molecules of VgrG and one molecule of PAAR protein
are secreted during each secretion cycle [19,67]. As explained
below, the T6SS spike can be decorated bymany different effec-
tors at the same time and some effectors bind into the lumen
of the Hcp ring [88] thus potentially increasing the overall
efficiency of T6SS.8. Discovery of T6SS effectors
Many T6SS effectors were identified using mass spectrometry
analysis of supernatants of T6SSþ organisms. This led to
the initial discovery of VgrG in V. cholerae [2], Tse effectors in
P. aeruginosa [89], and many effectors of B. thailandensis [90],
S. marcescens [51] or V. parahaemolyticus [91]. Even though this
is a very straightforward and unbiased approach, it has its
own limitations. The biggest problem is that certain classes of
effectors, such as VgrG-associated proteins, are secreted at a
very low rate and thus the protein abundance in the super-
natant could be below the detection limit. Another problem
could be that some T6SS systems are tightly regulated and
trigger secretion in a response to an attack or environmental
clues [57–60].
An elegant approach to identify antibacterial effec-
tors was developed by Dong et al. [92] The principle of this
method is that T6SSþ organisms that secrete antibacterial
effectors use specific immunity proteins to block their
action during growth in close contact with sister cells. If an
immunity gene is disrupted by transposon mutagenesis,
such a mutant will be killed by its T6SSþ neighbours. Viabi-
lity of mutants in the presence or absence of active T6SS is
then scored using deep sequencing. Mapping these T6SS-
dependent immunity proteins helps to identify cognate
effectors that are usually located in the same operon [92].
This approach is, however, limited to effectors that have
exactly one cognate immunity protein targeted into the
periplasm of the effector cell.Another interesting mass spectrometry method was
based on the fact that some Hcp-binding effectors are less
stable in the absence of Hcp [88,93]. An advantage of this
method is that proteins that are active in the cytosol or are
not necessarily toxic against bacteria can be detected, but
only in the case of their inherent instability in the absence
of Hcp [93].
Bioinformatics has proved to be a useful approach for
finding new effectors for various secretion systems including
T6SS [94]. Some T6SS effectors are part of characteristic gene
clusters or have certain physical properties such as pI or
size, which facilitates their identification [90]. Furthermore,
certain conserved domains are found present in T6SS effec-
tors, such as PAAR [67,95] or the MIX domain first found
in V. parahaemolyticus [91]. It is also now clear that many
effectors are located in the operons together with their
cognate VgrG, Hcp or PAAR proteins [88,96,97].9. Mechanism of effector secretion
We can conceptually divide T6SS effectors based on various
criteria. For example, based on a target, we can divide effectors
into antibacterial, anti-eukaryotic or being active against both
targets as shown recently [98,99]. Not all T6SS substrates
need to be necessarily toxic to target cells. In Y. pseudotubercu-
losis, a T6SS substrate YezP was shown to bind to Zn2þ and
increase its acquisition, and thus helps the bacteria to survive
stress and host immunity during pathogenesis [100]. We can
also characterize the effectors based on their structure and
mechanism of secretion. Here, I will only briefly discuss the
mechanisms of effector secretion. For very comprehensive
recent reviews of T6SS effectors and their function refer to
Durand et al. [14] and Russell et al. [15].
The current model of how effectors are secreted out of the
cells is based on what we know about the overall structure
and dynamics of T6SS and also based on the structural and
functional homology to contractile phage tails (figure 1).
VgrGs were the first class of proteins shown to be secreted
out of T6SSþ cells [2]. VgrGs are structural homologues of
the phage spike complex and even though VgrG–Hcp inter-
action was only shown in A. tumefaciens [52], it is believed
that VgrG forms a trimer at the very end of an Hcp tube
[19,20]. The VgrG N-terminal domain forms a pseudo-dimer
that has a fold similar to Hcp dimer, and therefore VgrG
trimer docks nicely to Hcp hexamer [19].
The first discovered T6SS effector was so-called ‘evolved’
VgrG protein, with VgrG N-terminal domain and actin cross-
linking effector domain at the C-terminus [20]. Since then,
more VgrG fusion effectors were characterized, such as mem-
brane fusion mediating VgrG-5 of B. pseudomallei [101,102],
actin ADP-ribosylating VgrG1 of Aeromonas hydrophila [103],
or peptidoglycan hydrolysing VgrG-3 of V. cholerae [92,104].
Secretion of several effectors is dependent on a particular
VgrG, like TseL of V. cholerae or Tse5 and Tse6 of P. aeruginosa
[92,93]. Interestingly, chaperone proteins that load effectors
onto their cognate VgrGs but are not secreted were discov-
ered recently in V. cholerae [105,106]. Searching for these
conserved proteins led also to identification of genetically
linked effectors in A. hydrophila [105]. This mechanism
could provide another level of regulation since expression
of different chaperone proteins could lead to loading of
different combinations of effectors onto a spike.
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Phil.Trans.R.Soc.B
370:20150021
7
 on November 10, 2015http://rstb.royalsocietypublishing.org/Downloaded from VgrG trimer is sharpened by a small PAAR protein, which
is a structural component essential for T6SS function. Similarly
to VgrG, PAAR proteins may bind or be fused to effectors [67].
For example, large Rhs-domain containing T6SS effectors of
S. marcescens, P. aeruginosa or Proteus mirabilis contain a
PAAR domain [93,107–109]. Importantly, a fully assembled
VgrG/PAAR spike is needed for proper T6SS function and
Hcp secretion [2,20,67]. Moreover, it seems that deletion of sev-
eral spike-associated effectors can also lead to a decrease of
T6SS activity [92]. This suggests that a certain mechanism con-
trols full assembly to prevent wasteful secretion of a spike that
lacks effectors.
Many structures of Hcp proteins are available and all Hcp
proteins form a hexameric ring with an inner diameter of
approximately 4 nm [6,70,72,110,111]. Interestingly, Hcp was
shown to have a chaperone-like activity and bind small effec-
tors in A. tumefaciens, E. tarda and P. aeruginosa [7,52,88,112].
Moreover, examples of Hcp with extension domains were
found as well [113]. Overall, it is becoming clear that the effec-
tors are loaded onto the extended T6SS during the assembly as
a fusion to or by an interaction with the secreted structural
components and then secreted all at once together with the
Hcp/VgrG/PAAR protein complex [67].
The example of P. aeruginosa H1-T6SS shows that different
substrates can be secreted by distinct mechanisms from the
same organisms [93]. It is, however, not clear whether the
same T6SS machine can indeed deliver multiple effectors in a
single contraction event or if multiple assemblies are required.
It is also not clear whether the Hcp tube is fully loadedwith its
interacting effectors or if binding of effectors is only sparse.
Another unresolved question is where exactly the effectors
are located on the VgrG/PAAR spike and how large a cargo
can be loaded at once. Clearly, a sharp tip evolved to facilitate
membrane puncturing in both T6SS and phages [67,114].
Therefore, it seems unlikely that effectors are directly on the
tip of VgrG/PAAR and are more likely on the side of the
VgrG as is lysozyme on gp5 of the T4 phage spike [115].
Mechanical puncturing of a membrane to deliver large
folded hydrophilic effectors would be necessary and thus
there are probably certain physical limits to how large effec-
tors can be. On the other hand, Rhs are known to form a large
beta-stranded cage that encapsulates toxic molecules in an
unfolded state and can open to release then upon a signal
[80,116], and thus the fact that Rhs can be substrate of T6SS
shows that the size limits might be relatively high.
Interestingly, antibacterial effectors with both periplasmic
and cytosolic targets are secreted by T6SS [89,93,96]. Even
though Hcp tubes are presumably long enough to reach the
target cell cytosol [26], it is not clear how far into the bacterial
cell can the Hcp/VgrG/PAAR with the associated effectors
be delivered. There are several options: (i) all effectors are
delivered into the periplasm of the target cell and use separ-
ate mechanisms to cross the inner membrane, (ii) effectors are
delivered into the cytosol and then some are transported to
the periplasm, or (iii) physical properties of an effector dictate
in which compartment it dissociates from the tube or spike.
R-type pyocins of P. aeruginosa or Clostridium difficile can
punch a hole into a bacterial cell by a contraction of its tail
[117–119]. The stable inner tube that remains inserted in the
cell envelope creates a conduit for ions and ion leakage from
thebacterial cell then leads to the cell death [46]. Thismechanism
is so potent that a single pyocin particle can kill a single bacterial
cell [120] and can be used to target various bacterial pathogensand treat infections [121,122]. This is in contrast to T6SS where
the killing of target cells has so far been associated only with
functions of effectors that are being secreted by T6SS. This
suggests that theHcp tube is probably not stable andmere punc-
turing of the target cells by T6SS is not lethal. Indeed, unlike in
phages or pyocins, the Hcp tube has not yet been detected as a
stable structure ejected from a contracted sheath. It is likely
that if the Hcp tube were stable, the T6SSþ cells would need a
mechanism to specifically remove the Hcp tube from their cell
envelope, for example by a specific cleavage, to allow quick
sealing of the membranes to prevent their own death.10. Concluding remarks
Many secretion systems have evolved to deliver proteins from
bacterial cell cytosol to the extracellular space or across the
target cell membrane. These systems vary in structure and
mechanism of secretion and therefore also in the efficiency
of translocation. Energetics of the T6SS is particularly inter-
esting considering the fact that it seems as if only few
molecules of spike-associated effectors are secreted with
each contraction and since the T6SS seems relatively costly,
considering the loss of Hcp and potentially large consump-
tion of ATP during refolding of the contracted sheath. What
are really the benefits of the T6SS mode of action? Why is
T6SS used to secrete proteins? What are the main advantages
of this mechanism of secretion?
One advantage could be that in the case of effectors that are
preloaded into the Hcp tube, in one step, which can be accom-
plished in only a few tens of seconds, tens of various effectors
could be delivered into the target cell at once. The second
advantage is that a large amount of energy is potentially
released during the contraction and this could be necessary
for puncturing the target cell membranes. Delivery of folded
hydrophilic proteins across membranes requires breakage of
large amount of hydrophobic interactions between membrane
lipids. This problem can be solved by an evolution of a trans-
membrane domain that inserts amphipathic segments into
the membrane to create a hydrophilic conduit for the translo-
cated protein. However, such a mechanism has to adapt to
various membrane compositions and has potential limitations
on the fold of the translocated protein. In the case of T6SS, the
physical rupture of the target cell membrane might be enough
to push large substrates across without a need for a protein
dedicated to engage the membrane and potentially also
without a limit to the structure of the translocated protein.
This might be the reason why membrane translocation
by physical puncturing is conserved in many related systems:
R-type pyocins and phages targeting bacteria [24], but also
similar nanomachines targeting eukaryotes, such as antifeed-
ing prophage [123], metamorphosis-associated contractile
structures [124] or Photorhabdus virulence cassette [125]. There
is nodoubt that further studies of dynamics, structure and func-
tion of these fascinating nanomachines will help us to fully
unravel their mode of action and unlock their potential use
for cargo delivery.
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